Braveheart Bio (NASDAQ:BRVE – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $40.00 price objective on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 108.22% from the stock’s previous close. Other analysts have […]

FB Financial (NYSE:FBK – Get Free Report)‘s stock had its “overweight” rating reaffirmed by stock analysts at Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They currently have a $65.00 target price on the financial services provider’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 28.41% from the company’s previous close. […]

Omeros (NASDAQ:OMER – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research note issued on Wednesday, Marketbeat reports. They currently have a $22.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 16.53% from the company’s previous close. Several […]

Cantor Fitzgerald reissued their overweight rating on shares of Dycom Industries (NYSE:DY – Free Report) in a research note published on Friday morning,Benzinga reports. The firm currently has a $476.00 target price on the construction company’s stock. A number of other research firms have also recently issued reports on DY. Weiss Ratings cut shares of […]